2012 12 06 - LOINC Introduction - Brief
2012 12 06 - LOINC Introduction - Brief
2012.12.06
2012
loinc.org/slideshows
Acknowledgements
LOINC Development Team
Kathy Mercer, Jaci Phillips, Jami Deckard, Kelly Malott, David Baorto, Clem McDonald
Origins of LOINC
The lingua franca of clinical observation exchange
McDonald et al. Canopy Computing: using the Web in Clinical Practice. JAMA. 1998;280(15):1325-1329.
The rain forest canopy is a seamless web through which arboreal creatures efficiently move to reach the edible fruits without any attention to the individual trees.
McDonald et al. Canopy Computing: using the Web in Clinical Practice. JAMA. 1998;280(15):1325-1329. photo via nosha
Regenstrief
the Data Switzerland
Fundamental challenge:
Local systems have different ways of identifying the same concept.
MEASUREMENTS R US
photo via puuikibeach
LOINC provides codes for questions Where needed, other vocabularies provide codes for answers
MSH|^~\&|HOSPITAL_A|SAMPLE_HOSPITAL_A|||$YearMonthDay||||||||||||||| PID|||$patientId$||$patientName$|||||||||||||||||||| PV1|||||||$attendingDoctor$||$consultingDoctor$|||||||| OBR|1|||012^CBC/Auto Diff^HSPA^57021-8^CBC W Auto Diff^LN||$reqDate||||||||| OBX|2|NM|123^WBC^HSP_A^26464-8^Leukocytes [#/volume] in Blood^LN||10.8|K/MM3|||||F| OBX|3|NM|234^RBC^HSP_A^26453-1^Erythrocytes [#/volume] in Blood^LN||4.82|MIL/MM3|||||F| OBX|4|NM|345^HGB^HSP_A^718-7^Hemoglobin [Mass/volume] in Blood^LN||15.7|GM/DL|||||F| OBX|5|NM|456^HCT^HSP_A^20570-8^Hematocrit [Volume Fraction] of Blood^LN||45|%|||||||F|
MSH|^~\&|HOSPITAL_A|SAMPLE_HOSPITAL_A|||$YearMonthDay||||||||||||||| PID|||$patientId$||$patientName$|||||||||||||||||||| PV1|||||||$attendingDoctor$||$consultingDoctor$|||||||| OBR|1|||012^CBC/Auto Diff^HSPA^57021-8^CBC W Auto Diff^LN||$reqDate||||||||| OBX|2|NM|123^WBC^HSP_A^26464-8^Leukocytes [#/volume] in Blood^LN||10.8|K/MM3|||||F| OBX|3|NM|234^RBC^HSP_A^26453-1^Erythrocytes [#/volume] in Blood^LN||4.82|MIL/MM3|||||F| OBX|4|NM|345^HGB^HSP_A^718-7^Hemoglobin [Mass/volume] in Blood^LN||15.7|GM/DL|||||F| OBX|5|NM|456^HCT^HSP_A^20570-8^Hematocrit [Volume Fraction] of Blood^LN||45|%|||||||F|
MSH|^~\&|HOSPITAL_A|SAMPLE_HOSPITAL_A|||$YearMonthDay||||||||||||||| PID|||$patientId$||$patientName$|||||||||||||||||||| PV1|||||||$attendingDoctor$||$consultingDoctor$|||||||| OBR|1|||012^CBC/Auto Diff^HSPA^57021-8^CBC W Auto Diff^LN||$reqDate||||||||| OBX|2|NM|123^WBC^HSP_A^26464-8^Leukocytes [#/volume] in Blood^LN||10.8|K/MM3|||||F| OBX|3|NM|234^RBC^HSP_A^26453-1^Erythrocytes [#/volume] in Blood^LN||4.82|MIL/MM3|||||F| OBX|4|NM|345^HGB^HSP_A^718-7^Hemoglobin [Mass/volume] in Blood^LN||15.7|GM/DL|||||F| OBX|5|NM|456^HCT^HSP_A^20570-8^Hematocrit [Volume Fraction] of Blood^LN||45|%|||||||F|
MSH|^~\&|HOSPITAL_A|SAMPLE_HOSPITAL_A|||$YearMonthDay||||||||||||||| PID|||$patientId$||$patientName$|||||||||||||||||||| PV1|||||||$attendingDoctor$||$consultingDoctor$|||||||| OBR|1|||012^CBC/Auto Diff^HSPA^57021-8^CBC W Auto Diff^LN||$reqDate||||||||| OBX|2|NM|123^WBC^HSP_A^26464-8^Leukocytes [#/volume] in Blood^LN||10.8|K/MM3|||||F| OBX|3|NM|234^RBC^HSP_A^26453-1^Erythrocytes [#/volume] in Blood^LN||4.82|MIL/MM3|||||F| OBX|4|NM|345^HGB^HSP_A^718-7^Hemoglobin [Mass/volume] in Blood^LN||15.7|GM/DL|||||F| OBX|5|NM|456^HCT^HSP_A^20570-8^Hematocrit [Volume Fraction] of Blood^LN||45|%|||||||F|
MSH|^~\&|HOSPITAL_A|SAMPLE_HOSPITAL_A|||$YearMonthDay||||||||||||||| PID|||$patientId$||$patientName$|||||||||||||||||||| PV1|||||||$attendingDoctor$||$consultingDoctor$|||||||| OBR|1|||012^CBC/Auto Diff^HSPA^57021-8^CBC W Auto Diff^LN||$reqDate||||||||| OBX|2|NM|123^WBC^HSP_A^26464-8^Leukocytes [#/volume] in Blood^LN||10.8|K/MM3|||||F| OBX|3|NM|234^RBC^HSP_A^26453-1^Erythrocytes [#/volume] in Blood^LN||4.82|MIL/MM3|||||F| OBX|4|NM|345^HGB^HSP_A^718-7^Hemoglobin [Mass/volume] in Blood^LN||15.7|GM/DL|||||F| OBX|5|NM|456^HCT^HSP_A^20570-8^Hematocrit [Volume Fraction] of Blood^LN||45|%|||||||F|
MSH|^~\&|HOSPITAL_A|SAMPLE_HOSPITAL_A|||$YearMonthDay||||||||||||||| PID|||$patientId$||$patientName$|||||||||||||||||||| PV1|||||||$attendingDoctor$||$consultingDoctor$|||||||| OBR|1|||012^CBC/Auto Diff^HSPA^57021-8^CBC W Auto Diff^LN||$reqDate||||||||| OBX|2|NM|123^WBC^HSP_A^26464-8^Leukocytes [#/volume] in Blood^LN||10.8|K/MM3|||||F| OBX|3|NM|234^RBC^HSP_A^26453-1^Erythrocytes [#/volume] in Blood^LN||4.82|MIL/MM3|||||F| OBX|4|NM|345^HGB^HSP_A^718-7^Hemoglobin [Mass/volume] in Blood^LN||15.7|GM/DL|||||F| OBX|5|NM|456^HCT^HSP_A^20570-8^Hematocrit [Volume Fraction] of Blood^LN||45|%|||||||F|
MSH|^~\&|HOSPITAL_A|SAMPLE_HOSPITAL_A|||$YearMonthDay||||||||||||||| PID|||$patientId$||$patientName$|||||||||||||||||||| PV1|||||||$attendingDoctor$||$consultingDoctor$|||||||| OBR|1|||012^CBC/Auto Diff^HSPA^57021-8^CBC W Auto Diff^LN||$reqDate||||||||| OBX|2|NM|123^WBC^HSP_A^26464-8^Leukocytes [#/volume] in Blood^LN||10.8|K/MM3|||||F| OBX|3|NM|234^RBC^HSP_A^26453-1^Erythrocytes [#/volume] in Blood^LN||4.82|MIL/MM3|||||F| OBX|4|NM|345^HGB^HSP_A^718-7^Hemoglobin [Mass/volume] in Blood^LN||15.7|GM/DL|||||F| OBX|5|NM|456^HCT^HSP_A^20570-8^Hematocrit [Volume Fraction] of Blood^LN||45|%|||||||F|
LocalCode^LocalName^CodeSystem^LOINCcode^LOINCname^CodeSystem
MSH|^~\&|HOSPITAL_A|SAMPLE_HOSPITAL_A|||$YearMonthDay||||||||||||||| PID|||$patientId$||$patientName$|||||||||||||||||||| PV1|||||||$attendingDoctor$||$consultingDoctor$|||||||| OBR|1|||012^CBC/Auto Diff^HSPA^57021-8^CBC W Auto Diff^LN||$reqDate||||||||| OBX|2|NM|123^WBC^HSP_A^26464-8^Leukocytes [#/volume] in Blood^LN||10.8|K/MM3|||||F| OBX|3|NM|234^RBC^HSP_A^26453-1^Erythrocytes [#/volume] in Blood^LN||4.82|MIL/MM3|||||F| OBX|4|NM|345^HGB^HSP_A^718-7^Hemoglobin [Mass/volume] in Blood^LN||15.7|GM/DL|||||F| OBX|5|NM|456^HCT^HSP_A^20570-8^Hematocrit [Volume Fraction] of Blood^LN||45|%|||||||F|
LocalCode^LocalName^CodeSystem^LOINCcode^LOINCname^CodeSystem
MSH|^~\&|HOSPITAL_A|SAMPLE_HOSPITAL_A|||$YearMonthDay||||||||||||||| PID|||$patientId$||$patientName$|||||||||||||||||||| PV1|||||||$attendingDoctor$||$consultingDoctor$|||||||| OBR|1|||012^CBC/Auto Diff^HSPA^57021-8^CBC W Auto Diff^LN||$reqDate||||||||| OBX|2|NM|123^WBC^HSP_A^26464-8^Leukocytes [#/volume] in Blood^LN||10.8|K/MM3|||||F| OBX|3|NM|234^RBC^HSP_A^26453-1^Erythrocytes [#/volume] in Blood^LN||4.82|MIL/MM3|||||F| OBX|4|NM|345^HGB^HSP_A^718-7^Hemoglobin [Mass/volume] in Blood^LN||15.7|GM/DL|||||F| OBX|5|NM|456^HCT^HSP_A^20570-8^Hematocrit [Volume Fraction] of Blood^LN||45|%|||||||F|
LocalCode^LocalName^CodeSystem^LOINCcode^LOINCname^CodeSystem
MSH|^~\&|HOSPITAL_A|SAMPLE_HOSPITAL_A|||$YearMonthDay||||||||||||||| PID|||$patientId$||$patientName$|||||||||||||||||||| PV1|||||||$attendingDoctor$||$consultingDoctor$|||||||| OBR|1|||012^CBC/Auto Diff^HSPA^57021-8^CBC W Auto Diff^LN||$reqDate||||||||| OBX|2|NM|123^WBC^HSP_A^26464-8^Leukocytes [#/volume] in Blood^LN||10.8|K/MM3|||||F| OBX|3|NM|234^RBC^HSP_A^26453-1^Erythrocytes [#/volume] in Blood^LN||4.82|MIL/MM3|||||F| OBX|4|NM|345^HGB^HSP_A^718-7^Hemoglobin [Mass/volume] in Blood^LN||15.7|GM/DL|||||F| OBX|5|NM|456^HCT^HSP_A^20570-8^Hematocrit [Volume Fraction] of Blood^LN||45|%|||||||F|
LocalCode^LocalName^CodeSystem^LOINCcode^LOINCname^CodeSystem
MSH|^~\&|HOSPITAL_A|SAMPLE_HOSPITAL_A|||$YearMonthDay||||||||||||||| PID|||$patientId$||$patientName$|||||||||||||||||||| PV1|||||||$attendingDoctor$||$consultingDoctor$|||||||| OBR|1|||012^CBC/Auto Diff^HSPA^57021-8^CBC W Auto Diff^LN||$reqDate||||||||| OBX|2|NM|123^WBC^HSP_A^26464-8^Leukocytes [#/volume] in Blood^LN||10.8|K/MM3|||||F| OBX|3|NM|234^RBC^HSP_A^26453-1^Erythrocytes [#/volume] in Blood^LN||4.82|MIL/MM3|||||F| OBX|4|NM|345^HGB^HSP_A^718-7^Hemoglobin [Mass/volume] in Blood^LN||15.7|GM/DL|||||F| OBX|5|NM|456^HCT^HSP_A^20570-8^Hematocrit [Volume Fraction] of Blood^LN||45|%|||||||F|
LocalCode^LocalName^CodeSystem^LOINCcode^LOINCname^CodeSystem
MSH|^~\&|HOSPITAL_A|SAMPLE_HOSPITAL_A|||$YearMonthDay||||||||||||||| PID|||$patientId$||$patientName$|||||||||||||||||||| PV1|||||||$attendingDoctor$||$consultingDoctor$|||||||| OBR|1|||012^CBC/Auto Diff^HSPA^57021-8^CBC W Auto Diff^LN||$reqDate||||||||| OBX|2|NM|123^WBC^HSP_A^26464-8^Leukocytes [#/volume] in Blood^LN||10.8|K/MM3|||||F| OBX|3|NM|234^RBC^HSP_A^26453-1^Erythrocytes [#/volume] in Blood^LN||4.82|MIL/MM3|||||F| OBX|4|NM|345^HGB^HSP_A^718-7^Hemoglobin [Mass/volume] in Blood^LN||15.7|GM/DL|||||F| OBX|5|NM|456^HCT^HSP_A^20570-8^Hematocrit [Volume Fraction] of Blood^LN||45|%|||||||F|
Code identifying this observation (what are these results? Conditions identied by newborn screening )
Code identifying this observation (what are these results? Conditions identied by newborn screening )
LOINC Terminology
LOINC Terminology
LOINC (noun)
LOINC Terminology
LOINC (noun) To LOINC, LOINCing, LOINCed (verb)
LOINC Terminology
LOINC (noun) To LOINC, LOINCing, LOINCed (verb) [Chief, Head, etc] LOINCer (noun)
LOINC Terminology
LOINC (noun) To LOINC, LOINCing, LOINCed (verb) [Chief, Head, etc] LOINCer (noun) LOINCification (noun)
From Standardizing the MDS with LOINC and Vocabulary Matches http:/ /aspe.hhs.gov/daltcp/reports/2007/MDS-LOINC.htm
LOINC Terminology
LOINC (noun)
To LOINC, LOINCing, LOINCed (verb) [Chief, Head, etc] LOINCer (noun) LOINCification (noun)
LOINC Terminology
LOINC (noun) To LOINC, LOINCing, LOINCed (verb) [Chief, Head, etc] LOINCer (noun) LOINCification (noun)
LOINC Terminology
LOINC (noun) To LOINC, LOINCing, LOINCed (verb) [Chief, Head, etc] LOINCer (noun) LOINCification (noun)
SNOMED Terminology
LOINC Terminology
LOINC (noun) To LOINC, LOINCing, LOINCed (verb) [Chief, Head, etc] LOINCer (noun) LOINCification (noun)
SNOMED Terminology
SNOMED (noun)
LOINC Terminology
LOINC (noun) To LOINC, LOINCing, LOINCed (verb) [Chief, Head, etc] LOINCer (noun) LOINCification (noun)
SNOMED Terminology
SNOMED (noun) SNOMEDicated???
LOINC Terminology
LOINC (noun) To LOINC, LOINCing, LOINCed (verb) [Chief, Head, etc] LOINCer (noun) LOINCification (noun)
SNOMED Terminology
SNOMED (noun) SNOMEDicated???
Laboratory LOINC
Clinical LOINC
LOINC Collections
Panels, forms, surveys, and other patient assessments
Vreeman DJ, McDonald CJ, Huff SM. Representing patient assessments in LOINC. AMIA Annu Symp Proc. 2010;832-836. PMID: 21347095 . Vreeman DJ, McDonald CJ, Huff SM. LOINC - A Universal Catalog of Individual Clinical Observations and Uniform Representation of Enumerated Collections. Int J Funct Inform Personal Med. 2010;3(4):273-291.
Open Development
Worldwide distribution at no cost New terms from end-users Welcome all comers Committees are volunteers
Open Development
Worldwide distribution at no cost New terms from end-users Welcome all comers Committees are volunteers
Open Development
Worldwide distribution at no cost New terms from end-users Welcome all comers Committees are volunteers
Its free, but invaluable
Regenstrief Institute
Steward Developer of content Developer of tools Developer of community Distributor Voice
Funding Support
Main current sources are:
U.S. National Library of Medicine Regenstrief Foundation Prior support from
Several other U.S. federal agencies, John A. Hartford Foundation
10,000!
LOINC Codes! Lab Codes!
20,000!
30,000!
40,000!
50,000!
60,000!
70,000!
80,000!
0!
4 5/ /24 2 / 6/ 4/ 199 2 1 6/ 3/1 9955 | 1 2 7/ 8/ 995 | 1 .0! .0 1 1 9/ 4/1 995 | 1 a! 12 15 99 | 1.0b /2 /19 5 | .0 ! 8/ 4/2 1/1 95 1.0 c! 2 8 9 | d 12 9/ /1 95 1.0 ! /3 19 99 | 1 e! /1 96 6 | .0 1 9 | 1 f! 10 /8/ 96 1.0 .0g /9 19 | 1. h(2 ! / 9 0 5/ 19 97 h(3)! 9 2/ 1/1 7 | | 1 )! 7/ 12 99 1. .0i! 2 / 8 0 8/ 3/1199 | 1 j-a! 6/ 9 9 .0 9 k 2/ 199 9 | | 1. ! 6/ 4/2 9 | 1. 0l! 13 0 1 0m 1/ /2 00 .0m ! 1/ 1/ 000 | 1 a! 31 20 | .0n 7/ /2 01 1.0 ! 1 0 | 1/ /2 01 2.00! 1 0 | 0 2/ /20 01 2.0 ! 2/ 1/ 02 | 2 1! 19 20 | .03 8/ /2 02 2.0 ! 1 0 | 4 9/ /2 02 2.0 ! 1 0 | 5 5/ /2 02 2.0 ! 10 1/ 002 | 2 6! /1 20 | .07 1/ /2 03 2.0 ! 1 0 | 8 2/ /2 03 2.0 ! 12 1/ 004 | 2 9! 2 .1 12/1/ 004 | 2 0! /1 20 | .11 6/ /2 04 2.1 ! 12 1/ 004 | 2 2! /1 20 | .13 6/ /2 05 2.1 ! 12 1/ 00 | 2 4! /2 20 5 | .15 6/ 1/ 06 2.1 ! 12 21 200 | 2 6! /0 /2 6| .17 7/ 3/ 007 2.1 ! 1 2 1/ 0/2007|2.29! 07 10 00 |2 1! . / 12/06 2008|2 22! /3 /2 9| .24 2/ 0/ 009 2.2 ! 2 2 6/ 6/ 009|2.26! 12 15 201 |2 7! . / 06/29 2010|2 29! / . 12/30 2010|2 30! /3 /2 0| .32 6/ 0/ 011 2.3 ! 30 20 |2 4! /2 11 .3 01 |2 6! 2| .38 2. ! 40 !
10,000!
LOINC Codes! Lab Codes!
20,000!
30,000!
40,000!
50,000!
60,000!
70,000!
80,000!
0!
Slope = 600
4 5/ /24 2 / 6/ 4/ 199 2 1 6/ 3/1 9955 | 1 2 7/ 8/ 995 | 1 .0! .0 1 1 9/ 4/1 995 | 1 a! 12 15 99 | 1.0b /2 /19 5 | .0 ! 8/ 4/2 1/1 95 1.0 c! 2 8 9 | d 12 9/ /1 95 1.0 ! /3 19 99 | 1 e! /1 96 6 | .0 1 9 | 1 f! 10 /8/ 96 1.0 .0g /9 19 | 1. h(2 ! / 9 0 5/ 19 97 h(3)! 9 2/ 1/1 7 | | 1 )! 7/ 12 99 1. .0i! 2 / 8 0 8/ 3/1199 | 1 j-a! 6/ 9 9 .0 9 k 2/ 199 9 | | 1. ! 6/ 4/2 9 | 1. 0l! 13 0 1 0m 1/ /2 00 .0m ! 1/ 1/ 000 | 1 a! 31 20 | .0n 7/ /2 01 1.0 ! 1 0 | 1/ /2 01 2.00! 1 0 | 0 2/ /20 01 2.0 ! 2/ 1/ 02 | 2 1! 19 20 | .03 8/ /2 02 2.0 ! 1 0 | 4 9/ /2 02 2.0 ! 1 0 | 5 5/ /2 02 2.0 ! 10 1/ 002 | 2 6! /1 20 | .07 1/ /2 03 2.0 ! 1 0 | 8 2/ /2 03 2.0 ! 12 1/ 004 | 2 9! 2 .1 12/1/ 004 | 2 0! /1 20 | .11 6/ /2 04 2.1 ! 12 1/ 004 | 2 2! /1 20 | .13 6/ /2 05 2.1 ! 12 1/ 00 | 2 4! /2 20 5 | .15 6/ 1/ 06 2.1 ! 12 21 200 | 2 6! /0 /2 6| .17 7/ 3/ 007 2.1 ! 1 2 1/ 0/2007|2.29! 07 10 00 |2 1! . / 12/06 2008|2 22! /3 /2 9| .24 2/ 0/ 009 2.2 ! 2 2 6/ 6/ 009|2.26! 12 15 201 |2 7! . / 06/29 2010|2 29! / . 12/30 2010|2 30! /3 /2 0| .32 6/ 0/ 011 2.3 ! 30 20 |2 4! /2 11 .3 01 |2 6! 2| .38 2. ! 40 !
10,000!
LOINC Codes! Lab Codes!
20,000!
30,000!
40,000!
50,000!
60,000!
70,000!
80,000!
0!
4 5/ /24 2 / 6/ 4/ 199 2 1 6/ 3/1 9955 | 1 2 7/ 8/ 995 | 1 .0! .0 1 1 9/ 4/1 995 | 1 a! 12 15 99 | 1.0b /2 /19 5 | .0 ! 8/ 4/2 1/1 95 1.0 c! 2 8 9 | d 12 9/ /1 95 1.0 ! /3 19 99 | 1 e! /1 96 6 | .0 1 9 | 1 f! 10 /8/ 96 1.0 .0g /9 19 | 1. h(2 ! / 9 0 5/ 19 97 h(3)! 9 2/ 1/1 7 | | 1 )! 7/ 12 99 1. .0i! 2 / 8 0 8/ 3/1199 | 1 j-a! 6/ 9 9 .0 9 k 2/ 199 9 | | 1. ! 6/ 4/2 9 | 1. 0l! 13 0 1 0m 1/ /2 00 .0m ! 1/ 1/ 000 | 1 a! 31 20 | .0n 7/ /2 01 1.0 ! 1 0 | 1/ /2 01 2.00! 1 0 | 0 2/ /20 01 2.0 ! 2/ 1/ 02 | 2 1! 19 20 | .03 8/ /2 02 2.0 ! 1 0 | 4 9/ /2 02 2.0 ! 1 0 | 5 5/ /2 02 2.0 ! 10 1/ 002 | 2 6! /1 20 | .07 1/ /2 03 2.0 ! 1 0 | 8 2/ /2 03 2.0 ! 12 1/ 004 | 2 9! 2 .1 12/1/ 004 | 2 0! /1 20 | .11 6/ /2 04 2.1 ! 12 1/ 004 | 2 2! /1 20 | .13 6/ /2 05 2.1 ! 12 1/ 00 | 2 4! /2 20 5 | .15 6/ 1/ 06 2.1 ! 12 21 200 | 2 6! /0 /2 6| .17 7/ 3/ 007 2.1 ! 1 2 1/ 0/2007|2.29! 07 10 00 |2 1! . / 12/06 2008|2 22! /3 /2 9| .24 2/ 0/ 009 2.2 ! 2 2 6/ 6/ 009|2.26! 12 15 201 |2 7! . / 06/29 2010|2 29! / . 12/30 2010|2 30! /3 /2 0| .32 6/ 0/ 011 2.3 ! 30 20 |2 4! /2 11 .3 01 |2 6! 2| .38 2. ! 40 !
Lots Cooking
Always more lab tests Genetic reporting Lots of survey instruments, forms, and assessments More radiology reports Structured document titles
10,000
15,000
20,000
5,000
loinc.org members
6/ 1/ 08 12 /1 /0 8 6/ 1/ 09 12 /1 /0 9 6/ 1/ 10 12 /1 /1 0 6/ 1/ 11 12 /1 /1 1 6/ 1/ 12
loinc.org members
20,000
15,000
10,000
5,000
6/ 1/ 08 12 /1 /0 8 6/ 1/ 09 12 /1 /0 9 6/ 1/ 10 12 /1 /1 0 6/ 1/ 11 12 /1 /1 1 6/ 1/ 12
loinc.org members
20,000
15,000
Doubled in 19 months!
10,000
5,000
6/ 1/ 08 12 /1 /0 8 6/ 1/ 09 12 /1 /0 9 6/ 1/ 10 12 /1 /1 0 6/ 1/ 11 12 /1 /1 1 6/ 1/ 12
loinc.org members
20,000
15,000
10,000
5,000
6/ 1/ 08 12 /1 /0 8 6/ 1/ 09 12 /1 /0 9 6/ 1/ 10 12 /1 /1 0 6/ 1/ 11 12 /1 /1 1 6/ 1/ 12
@LOINC
search.loinc.org
search.loinc.org
forum.loinc.org
loinc.org/usage
loinc.org/usage
loinc.org/usage
loinc.org/usage
loinc.org/usage
loinc.org/terms-of-use
Just kidding. Copyright is a good thing for standards. Its the licensing part that is interesting.
CANNOT use any Licensed Material to develop or promulgate a different standard for orders or observations.
International Adoption
participation, translation, implementation
LOINC Submitters
Since 2009:
LOINC Translators
22 organizations
Vreeman DJ et al. Enabling international adoption of LOINC through translation. J Biomed Inform (2012), doi:10.1016/j.jbi.2012.01.005
Vreeman DJ et al. Enabling international adoption of LOINC through translation. J Biomed Inform (2012), doi:10.1016/j.jbi.2012.01.005
1 International
st
Vreeman DJ et al. Enabling international adoption of LOINC through translation. J Biomed Inform (2012), doi:10.1016/j.jbi.2012.01.005
Large Implementations
SIGA Sade project Canada Health Infoway ePSOS Assistance publique - Hpitaux de Paris BiTAC Hong Kong Hospital Authority Philippine Health Insurance Corporation
Many more...
For the last few years, the AP-HP has been using the LOINC international nomenclature Thanks to this catalogue, the AP-HP is able to use the nomenclature in its treatment processes, whenever biology analyses and test results are requested.
Talking about LOINC at the Thai Ministry of Information and Communication Technology
This agreement further solidifies the wonderful relationship HL7 has enjoyed with Regenstrief for many years.
- Bob Dolin, MD
Chair of HL7 Board of Directors
US Adoption
A few key highlights
Stage 1
through 2013
Stage 2
starting 2014
vsac.nlm.nih.gov
ivdconnectivity.org
Ongoing Journey
Plan for updating as your testing changes (less common), or your local code identiers change (more common).
Ongoing Journey
Replace mappings to deprecated terms with new LOINC releases. (RELMA can help)
Prioritization
Local or national policies may help prioritize mapping subsets. For example:
common results + panel elements + public health reportable tests
Jump In!
Happy LOINCing!
200
400
600
800
1000
1200
1400
1600
1800
2000
6/ 8/ 1/ 1/ 08
LOINC Downloads
10 08 /1 / 12 08 /1 /0 2/ 8 1/ 0 4/ 9 1/ 0 6/ 9 1/ 0 8/ 9 1/ 10 09 /1 / 12 09 /1 /0 2/ 9 1/ 1 4/ 0 1/ 1 6/ 0 1/ 1 8/ 0 1/ 10 10 /1 / 12 10 /1 /1 2/ 0 1/ 1 4/ 1 1/ 1 6/ 1 1/ 1 8/ 1 1/ 10 11 /1 / 12 11 /1 /1 2/ 1 1/ 1 4/ 2 1/ 1 6/ 2 1/ 1 8/ 2 1/ 10 12 /1 /1 2